UroViu launches a new single-use hysteroscope
“I found the UroViu endoscope to be perfect for in-office hysteroscopy due to its wider field of view and low price. The image quality was superior to any disposable endoscope I’ve worked with before,” said Dr. Darin Swainstonobstetrician-gynecologist at Women’s Health Associates of Southern Nevada. “Hysteroscopy with endometrial biopsy has become the standard of care. UroViu is an excellent product to meet this need.”
The Hystero-V is UroViu’s 4th FDA-510k cleared single-use endoscopic solution from UroViu and is compatible with UroViu’s Always Ready Endoscopy Platform, which until now consisted of a self-contained, reusable portable handle and three single-use cystoscopes optimized for the procedure. Single-use endoscopes eliminate the large initial capital expenditure and reprocessing costs of reusable hysteroscopes and cystoscopes, improving the economics of endoscopy.
“UroViu’s innovative single-use endoscopy platform now offers even more cost-effective and safe solutions for busy urologists, urogynecologists and gynecologists,” said Bruce OuYang, Founder and CEO of UroViu. “Every physician with this small rig in their hand can increase procedure volume through improved productivity without compromising patient comfort and safety.”
The Cystoscopy and Hysteroscopy Platform, the Most Comprehensive Single-Use Portable Endoscope Suite for Urogynecology, to be Featured at the American Urogynecology Society (AUGS)/International Urogynecological Association (IUGA) Combined Scientific Meeting 2022 from June 15-17 in Austin, TX to Austin Congress Palace. AUGS/IUGA serves more than 5,000 members worldwide in urogynecology, female pelvic medicine and reconstructive surgery.
The UroViu team will be providing hands-on demonstrations of the Hystero-V and Always Ready Platform at booth #417 of the AUGS exhibition, which will then be available for ordering from July, 1st.
UroViu is committed to introducing the latest advances in patient care and bringing additional innovations in the field of single-use endoscopy for urology, urogynecology and gynecology indications. The Hystero-V is the latest of many advancements in UroViu’s pursuit of excellence in women’s health technology.
UroViu Corporation’s mission is to revolutionize the Cystoscopy and Hysteroscopy platform to improve patient care and efficiency and operates in California and Washington and production facilities at Asia. UroViu is the developer of the ever-ready cystoscopy and hysteroscopy platform, the most portable, self-contained and versatile single-use endoscopy solution on the market. The intuitive wearable platform and product suite are protected by a portfolio of 20 granted patents and numerous patents pending. UroViu’s vision is to simplify the scope of patient care.